These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20665144)

  • 1. A combination treatment with SAHA and ad-p63/p73 shows an enhanced anticancer effect in HNSCC.
    Shim SH; Lee CT; Lee JJ; Kim SY; Hah JH; Heo DS; Sung MW
    Tumour Biol; 2010 Dec; 31(6):659-66. PubMed ID: 20665144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p73 beta-expressing recombinant adenovirus: a potential anticancer agent.
    Das S; Nama S; Antony S; Somasundaram K
    Cancer Gene Ther; 2005 Apr; 12(4):417-26. PubMed ID: 15678153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential role of caspase-8 in p53/p73-dependent apoptosis induced by etoposide in head and neck carcinoma cells.
    Liu J; Uematsu H; Tsuchida N; Ikeda MA
    Mol Cancer; 2011 Jul; 10():95. PubMed ID: 21801448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis through both mitochondrial and Fas (Cd95) signaling in head and neck squamous carcinoma cells.
    Gillenwater AM; Zhong M; Lotan R
    Mol Cancer Ther; 2007 Nov; 6(11):2967-75. PubMed ID: 18025281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma.
    Ory B; Ramsey MR; Wilson C; Vadysirisack DD; Forster N; Rocco JW; Rothenberg SM; Ellisen LW
    J Clin Invest; 2011 Feb; 121(2):809-20. PubMed ID: 21293058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis.
    Choi HR; Batsakis JG; Zhan F; Sturgis E; Luna MA; El-Naggar AK
    Hum Pathol; 2002 Feb; 33(2):158-64. PubMed ID: 11957139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53, p63 and p73 expression in squamous cell carcinomas of the head and neck and their response to cisplatin exposure.
    Gwosdz C; Balz V; Scheckenbach K; Bier H
    Adv Otorhinolaryngol; 2005; 62():58-71. PubMed ID: 15608418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suberoylanilide hydroxamic acid inhibits growth of head and neck cancer cell lines by reactivation of tumor suppressor microRNAs.
    Datta J; Islam M; Dutta S; Roy S; Pan Q; Teknos TN
    Oral Oncol; 2016 May; 56():32-9. PubMed ID: 27086484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis.
    Rocco JW; Leong CO; Kuperwasser N; DeYoung MP; Ellisen LW
    Cancer Cell; 2006 Jan; 9(1):45-56. PubMed ID: 16413471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: potential application to gene therapy of colorectal cancer.
    Sasaki Y; Morimoto I; Ishida S; Yamashita T; Imai K; Tokino T
    Gene Ther; 2001 Sep; 8(18):1401-8. PubMed ID: 11571580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer.
    Lu H; Yan C; Quan XX; Yang X; Zhang J; Bian Y; Chen Z; Van Waes C
    Neoplasia; 2014 Oct; 16(10):789-800. PubMed ID: 25379016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of gefitinib effectiveness in a broad panel of head and neck squamous carcinoma cells.
    Sebastian S; Azzariti A; Accardi R; Conti D; Pilato B; LaCalamita R; Porcelli L; Simone GM; Tommasi S; Tommasino M; Paradiso A
    Int J Mol Med; 2008 Jun; 21(6):809-17. PubMed ID: 18506376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antineoplastic effect of DLC1 tumor suppressor protein and histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), on prostate and liver cancer cells: perspectives for therapeutics.
    Zhou X; Yang XY; Popescu NC
    Int J Oncol; 2010 Apr; 36(4):999-1005. PubMed ID: 20198346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?
    Faridoni-Laurens L; Bosq J; Janot F; Vayssade M; Le Bihan ML; Kaghad M; Caput D; BĂ©nard J; Ahomadegbe JC
    Oncogene; 2001 Aug; 20(38):5302-12. PubMed ID: 11536043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p63 and p73: teammates or adversaries?
    Ratovitski E; Trink B; Sidransky D
    Cancer Cell; 2006 Jan; 9(1):1-2. PubMed ID: 16413463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer.
    Blumenschein GR; Kies MS; Papadimitrakopoulou VA; Lu C; Kumar AJ; Ricker JL; Chiao JH; Chen C; Frankel SR
    Invest New Drugs; 2008 Feb; 26(1):81-7. PubMed ID: 17960324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of 14-3-3sigma on transcriptional activity of p73 gene].
    Sang MX; Geng CZ; Shan BE
    Ai Zheng; 2007 May; 26(5):489-93. PubMed ID: 17672938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of an adenovirus expressing p73 beta, a p53 homologue, against human papilloma virus positive cervical cancer in vitro and in vivo.
    Das S; Somasundaram K
    Cancer Biol Ther; 2006 Feb; 5(2):210-7. PubMed ID: 16481734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells.
    Sun Q; Ming L; Thomas SM; Wang Y; Chen ZG; Ferris RL; Grandis JR; Zhang L; Yu J
    Oncogene; 2009 Jun; 28(24):2348-57. PubMed ID: 19421143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.